Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +2.27% | -8.16% | -73.10% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.14M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-0.46
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.74% |
Latest transcript on Processa Pharmaceuticals, Inc.
1 day | +2.27% | ||
1 week | -8.16% | ||
Current month | -17.43% | ||
1 month | -25.93% | ||
3 months | -18.18% | ||
6 months | -80.85% | ||
Current year | -73.10% |
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.8 | +2.27% | 9,839 |
24-05-23 | 1.76 | -4.35% | 31,651 |
24-05-22 | 1.84 | -3.16% | 28,234 |
24-05-21 | 1.9 | -2.06% | 45,113 |
24-05-20 | 1.94 | -1.02% | 30,413 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.10% | 5.14M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PCSA Stock